# Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

> **NCT00469755** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 302 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene Gel, 0.1%
- **DRUG:** Tazarotene Cream, 0.1%
- **DRUG:** Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%

## Key facts

- **NCT ID:** NCT00469755
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469755, "Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00469755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*